C. Ola Landgren, Leader, Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center, shared a post on X:
“Thank you very much Florida Society of Clinical Oncology (FLASCO) for inviting me to give a talk on “clinical applications for MRD testing in multiple myeloma” at the FLASCO Fall Congress, October 23-25, 2025 in Orlando!
Thank you also for inviting me to serve on the FLASCO Board of Directors beginning January 1, 2026.
I look forward to working together to advocate for cancer patients and their families, as well as oncology providers in Florida!
FLASCO is the state professional organization representing medical oncologists, hematologists, and oncology practices throughout Florida.
Its role is to improve healthcare policy at the state level; support oncology practices through education, business resources, and networking; and to ensure access to high-quality cancer care across urban and rural Florida. Florida ranks 3rd among US states by population, with ~23.8 million residents. This places it behind California (~39.0 million) and Texas (~31.0 million), but ahead of New York (~20.4 million).”
More posts featuring C Ola Landgren on OncoDaily.
